NCT07426484 2026-02-23
Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Phase 4 Not yet recruiting
Clinical Trials
9 trialsNCT00866684 2025-03-14
PROSKIN
Charite University, Berlin, Germany
Phase 4 Terminated
NCT04448873 2023-09-26
Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma
Children's Hospital of Fudan University
Phase 4 Completed
NCT04077515 2023-01-30
Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma
Children's Hospital of Fudan University
Phase 4 Completed
NCT02688881 2022-06-15
Study to Evaluate the Safety and Efficacy of Sirolimus, in Subject With Refractory Solid Tumors
Samsung Medical Center
Phase 4 Completed
NCT03781050 2019-01-23
Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome
Peking Union Medical College Hospital
Phase 4 Unknown
NCT03500367 2018-04-18
Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis
Peking Union Medical College Hospital
Phase 4 Unknown
NCT00129961 2012-04-11
Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 4 Completed
NCT01217125 2012-03-08
Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis
Fundacio Puigvert
Phase 4 Completed